Subjective outcome measurement_a primer Mary Patricia TullyJudith A. Cantrill OriginalPaper Pages: 101 - 109
Academic detailing improves identification and reporting of adverse drug events Raymond G. SchliengerThomas F. LüscherRonald A. Schoenenberger OriginalPaper Pages: 110 - 115
Asthma exacerbations during first therapy with long acting β2‐agonists C.M.J.M. GerritsR.M.C. HeringsJ‐W.J. Lammers OriginalPaper Pages: 116 - 119
The quality of Dutch hospital drug formularies: Evaluation of technical features and organisational information R. FijnS.A.G. EngelsC.J. De Blaey OriginalPaper Pages: 120 - 126
Technicians or patient advocates? − still a valid question Anna Birna Almarsd¢ttirJanine Marie Morgall OriginalPaper Pages: 127 - 131
Antidepressant drug choice for first users in two regions in the Netherlands A.C.G. EgbertsM. VeenstraL.T.W. de Jong - van den Berg OriginalPaper Pages: 132 - 136
Physico‐chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers Judith ThiesenIrene Krämer OriginalPaper Pages: 137 - 141
The role of the French community pharmacist in drug dispensing G. GhambaG. BauguilJ. Gallezot OriginalPaper Pages: 142 - 143
Long‐term stability of morphine and bupivacaine mixture for spinal use C.M. Essink-TjebbesD.M. BurgerY.A. Hekster OriginalPaper Pages: 144 - 146
Proceedings – ESCP27 th European Symposium on Clinical Pharmacy Evidence-Based Pharmaceutical Care, 26-28 October 1998, Jerusalem, Israel OriginalPaper Pages: 147 - 166